Previously published observations indicate that a member of the Eph group of receptor tyrosine kinases, EPHB4, suppresses TRAIL-induced apoptosis in some types of solid tumours, including breast cancer cells [20–22], indirectly suggesting that its signaling partners may also actively regulate this response in a positive or negative manner. The gene discussed is NTRK1; the disease is breast carcinoma.